论文部分内容阅读
目的:探讨采用同步放化疗治疗的方法对中晚期宫颈癌患者的治疗效果。方法:选取我院收治的86例中晚期宫颈癌患者依据随机平均原则分为对照组与观察组,对照组43例患者行单纯放疗,观察组43例患者行同步放化疗治疗。对两组患者的临床治疗效果、生存率及不良反应进行记录与分析。结果:观察组患者的临床有效率、3年生存率显著优于对照组,P<0.05;观察组胃肠道反应发生率、骨髓抑制率显著高于对照组,P<0.05。结论:对中晚期宫颈癌患者采取同步放化疗治疗能取得良好的近期效果,且远期生存率也较高,但可能导致一定的不良反应,尤其是胃肠道反应与骨髓抑制反应,但患者经治疗后一般均可耐受。
Objective: To explore the use of concurrent chemoradiotherapy for the treatment of advanced cervical cancer patients. Methods: A total of 86 patients with advanced cervical cancer admitted to our hospital were divided into control group and observation group according to the principle of randomization. 43 patients in control group received radiotherapy alone and 43 patients in observation group received concurrent chemoradiotherapy. The clinical treatment effect, survival rate and adverse reactions of two groups of patients were recorded and analyzed. Results: The clinical effective rate and 3-year survival rate in the observation group were significantly better than those in the control group (P <0.05). The incidence of gastrointestinal reactions and the bone marrow suppression rate in the observation group were significantly higher than those in the control group (P <0.05). Conclusions: The curative effect of concurrent chemoradiotherapy on patients with advanced cervical cancer can achieve good short-term effect and long-term survival rate, but may lead to some adverse reactions, especially gastrointestinal reactions and myelosuppression, but patients After treatment generally can be tolerated.